StockData
Surgery Partners, Inc. logo

Surgery Partners, Inc. (SGRY) stock

SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/3011% above fair value
$26.85+0.06 (+0.22%)

Close on Nov 17, 2026Market cap $3.52BP/E –Yield –

Surgery Partners operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Surgery Partners's operating cash flow for the twelve months ending Jun 30, 2026 was $258.00M, down 2.2% year over year. For fiscal 2025 it was $274.30M, down 8.6% from the year before. Over ten years it grew 28.7% a year on average. The highest annual figure on record is $300.10M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$274.30M-8.6%
FY2024Dec 31, 2024$300.10M+2.1%
FY2023Dec 31, 2023$293.80M+85.0%
FY2022Dec 31, 2022$158.80M+82.3%
FY2021Dec 31, 2021$87.10M-64.7%
FY2020Dec 31, 2020$246.90M+90.7%
FY2019Dec 31, 2019$129.50M-10.4%
FY2018Dec 31, 2018$144.60M+15.5%
FY2016Dec 31, 2016$125.24M+48.2%
FY2015Dec 31, 2015$84.48M+284.9%
FY2014Dec 31, 2014$21.95M-55.3%
FY2013Dec 31, 2013$49.08M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$59.30M-27.1%
Q1 FY2026Mar 31, 2026$11.70M+95.0%
Q4 FY2025Dec 31, 2025$103.40M-7.2%
Q3 FY2025Sep 30, 2025$83.60M+28.2%
Q2 FY2025Jun 30, 2025$81.30M-1.8%
Q1 FY2025Mar 31, 2025$6.00M-85.3%
Q4 FY2024Dec 31, 2024$111.40M+78.0%
Q3 FY2024Sep 30, 2024$65.20M-37.7%
Q2 FY2024Jun 30, 2024$82.80M+58.9%
Q1 FY2024Mar 31, 2024$40.70M-45.4%
Q4 FY2023Dec 31, 2023$62.60M+769.4%
Q3 FY2023Sep 30, 2023$104.60M+252.2%
Q2 FY2023Jun 30, 2023$52.10M+23.8%
Q1 FY2023Mar 31, 2023$74.50M-6.6%
Q4 FY2022Dec 31, 2022$7.20M-63.5%
Q3 FY2022Sep 30, 2022$29.70M+99.3%
Q2 FY2022Jun 30, 2022$42.10M+1730.4%
Q1 FY2022Mar 31, 2022$79.80M+59.0%
Q4 FY2021Dec 31, 2021$19.70M+121.3%
Q3 FY2021Sep 30, 2021$14.90M-44.6%
Q2 FY2021Jun 30, 2021$2.30M-98.7%
Q1 FY2021Mar 31, 2021$50.20M+71.9%
Q4 FY2020Dec 31, 2020$8.90M-65.0%
Q3 FY2020Sep 30, 2020$26.90M-52.7%
Q2 FY2020Jun 30, 2020$181.90M+581.3%
Q1 FY2020Mar 31, 2020$29.20M+42.4%
Q4 FY2019Dec 31, 2019$25.40M-44.2%
Q3 FY2019Sep 30, 2019$56.90M+92.9%
Q2 FY2019Jun 30, 2019$26.70M-32.6%
Q1 FY2019Mar 31, 2019$20.50M-31.7%
Q4 FY2018Dec 31, 2018$45.50M+110.6%
Q3 FY2018Sep 30, 2018$29.50M-15.4%
Q2 FY2018Jun 30, 2018$39.60M+22.3%
Q1 FY2018Mar 31, 2018$30.00M+59.4%
Q2 FY2017Jun 30, 2017$21.60M–
Q1 FY2017Mar 31, 2017$34.87M–
Q4 FY2016Dec 31, 2016$32.38M–
Q3 FY2016Sep 30, 2016$18.83M–

More Surgery Partners figures

See a number that looks wrong?